Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Grows By 87.3%

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 115,000 shares, an increase of 87.3% from the March 31st total of 61,400 shares. Approximately 4.5% of the company’s shares are sold short. Based on an average trading volume of 216,600 shares, the days-to-cover ratio is presently 0.5 days.

Silo Pharma Stock Performance

Shares of SILO stock traded down $0.03 during trading hours on Friday, hitting $1.85. The company had a trading volume of 55,867 shares, compared to its average volume of 440,773. Silo Pharma has a fifty-two week low of $1.22 and a fifty-two week high of $3.05. The company’s fifty day moving average is $1.80 and its 200 day moving average is $1.60.

About Silo Pharma

Silo Pharma. Inc, a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company's developing solutions to address various underserved conditions. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders.